University of British Columbia, Department of Emergency Medicine, Vancouver, British Columbia, Canada.
National Research Council of Canada, Medical Devices Research Center, Boucherville, Quebec, Canada.
AMIA Jt Summits Transl Sci Proc. 2022 May 23;2022:244-253. eCollection 2022.
The COVID-19 pandemic presented challenges to the healthcare system while catalyzing the adoption of virtual care. The need for remote assessment and real-time monitoring of physiological vital signs has driven towards a need for virtual care solutions. This paper presents the outcome of a multidisciplinary collaboration to ensure clinical usability of a remote contactless sensing technology, VitalSeer, and to help close gaps between emerging technologies and clinical practice. The paper describes the user-centric data-driven clinical approach to address the needs as identified by clinical experts through the iterative and agile development cycle. It highlights findings from preliminary studies to validate proof-of-concept VitalSeer's adoptability, accessibility and usability. The studies on volunteers demonstrated the accuracy of VitalSeer's heart rate model at a low MAE of 0.74 (bpm) and a RMSE of 1.2 bpm, below the threshold of clinical grade contact-based sensors. The paper concludes with a discussion on the technology implications in emergency medicine and community care.
COVID-19 大流行给医疗体系带来了挑战,同时也推动了虚拟医疗的采用。远程评估和实时监测生理生命体征的需求促使人们需要虚拟医疗解决方案。本文介绍了多学科合作的成果,以确保远程非接触式感应技术 VitalSeer 的临床可用性,并帮助弥合新兴技术与临床实践之间的差距。本文通过迭代和敏捷的开发周期,描述了以用户为中心的数据驱动型临床方法,以满足临床专家确定的需求。本文强调了初步研究的结果,以验证 VitalSeer 的可采用性、可及性和可用性的概念验证。志愿者研究表明, VitalSeer 的心率模型的准确性很高,MAE 为 0.74(bpm),RMSE 为 1.2 bpm,低于基于接触的临床级传感器的阈值。本文最后讨论了该技术在急诊医学和社区护理中的意义。